PT-141
Discuss PT-141 (bremelanotide) and sexual-health concerns with a licensed medical doctor. Your doctor reviews your history, risks, and whether any treatment is appropriate.
Doctor evaluation required
An informed conversation about your care.
- Sexual-health concerns and treatment goals
- Blood pressure and cardiovascular history
- Evidence, risks, and alternatives
- Pharmacy and formulation review
FDA approval applies to the specific branded bremelanotide medicine for a defined indication, not compounded PT-141. Bremelanotide is contraindicated in uncontrolled hypertension or known cardiovascular disease. Any prescribing or dispensing requires clinical review and confirmation of applicable pharmacy and regulatory requirements; availability is not guaranteed.
All care begins with a licensed U.S. medical doctor. Compounded medicines are not FDA-approved; the FDA does not review them for safety, effectiveness, or quality before marketing. Any 503A pharmacy fulfillment must meet applicable requirements and be confirmed for the individual patient. Listed topics do not guarantee treatment or availability.